Kbi-098 -

: A major contract development and manufacturing organization (CDMO) that specializes in biologics. While they manage numerous development programs, "KBI-098" does not appear as a standard public designation for their current internal pipeline or client-facing projects. 2. Criminal Justice and Public Safety

: Geological and forensic studies from 1998 sometimes use similar numbering for "Open File Reports" in the state of Kansas. Drug Research Formulation Lab - KBI Biopharma KBI-098

There is no definitive widely recognized entity, chemical compound, or project known as . Criminal Justice and Public Safety : Geological and

The identifier appears to be a combination of terms that relate to several distinct professional and scientific fields. To help clarify which "KBI-098" you are referring to, below is an analysis of how these components are typically used in specialized sectors: 1. Pharmacology and Drug Development To help clarify which "KBI-098" you are referring

: The Bureau often publishes annual reports or specific legislative documents that may use numbered designations (e.g., "98" referring to the year 1998 or a specific case file).

: A prominent small molecule being developed by BioVersys in collaboration with GSK to treat tuberculosis. It is designed to overcome antibiotic resistance and is currently in Phase 2 clinical trials.